Stay updated on Pembrolizumab for Rare Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T13:54:56.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.15.2) and the removal of an erratum related to a study on pembrolizumab in patients with advanced rare cancers.
    Difference
    0.4%
    Check dated 2025-05-01T06:19:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-24T01:01:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new cancer types and a revised version number, while significant details about the study's objectives and treatment protocols have been removed.
    Difference
    44%
    Check dated 2025-04-16T20:30:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 9, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T13:56:36.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include information on Adrenocortical Carcinoma and has removed references to Medullary Thyroid Cancer. Additionally, the last update date has changed to March 25, 2025, reflecting a more recent version of the content.
    Difference
    0.3%
    Check dated 2025-04-02T00:07:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.